It is characterized by a double pathophysiological alteration represented on one side by an increase in insulin resistance, that is, the inability of the action of blood circulating insulin, due to a resistance of the target tissues; on the other side, by a deficiency of insulin secretion from the pancreas [17]. Here, INS is linked to Insulin resistance.